Unraveling the transcriptional regulatory machinery in chondrogenesis

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 4, 2011, Pages 390-395

  Akiyama, Haruhiko ^a   Lefebvre, Véronique ^b  

^a KYOTO UNIVERSITY   (Japan)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chondrogenesis; SOX5; SOX6; SOX9; Transcription

Indexed keywords

BETA CATENIN; COLLAGEN TYPE 11; COLLAGEN TYPE 2; CYCLIC AMP DEPENDENT PROTEIN KINASE; RHO KINASE; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9;

CARTILAGE CELL; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CHONDRODYSPLASIA; CHONDROGENESIS; ENCHONDRAL OSSIFICATION; GENE ACTIVATION; GENE FUNCTION; GENE IDENTIFICATION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION;

CHONDROGENESIS; GENE EXPRESSION REGULATION; HUMANS; SOX TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 80052431167     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-011-0273-9     Document Type: Review

References (56)

1. Horton W, Miyashita T, Kohno K, Hassell JR, Yamada Y (1987) Identification of a phenotype-specific enhancer in the first intron of the rat collagen II gene. Proc Natl Acad Sci USA 84:8864-8868
2. Savagner P, Krebsbach PH, Hatano O, Miyashita T, Liebman J, Yamada Y (1995) Collagen II promoter and enhancer interact synergistically through Sp1 and distinct nuclear factors. DNA Cell Biol 14:501-510
3. Krebsbach PH, Nakata K, Bernier SM, Hatano O, Miyashita T, Rhodes CS, Yamada Y (1996) Identification of a minimum enhancer sequence for the type II collagen gene reveals several core sequence motifs in common with the link protein gene. J Biol Chem 271:4298-4303 (Pubitemid 26070536)
4. Lefebvre V, Garofalo S, Zhou G, Metsaranta M, Vuorio E, De Crombrugghe B (1994) Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol 14:329-335 (Pubitemid 24269080)
5. Mukhopadhyay K, Lefebvre V, Zhou G, Garofalo S, Kimura JH, De Crombrugghe B (1995) Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse proalpha 1(II) collagen gene. J Biol Chem 270:27711-27719
6. Foster JW, Dominguez-Steglich MA, Guioli S, Kowk G, Weller PA, Stevanovic M, Weissenbach J, Mansour S, Young ID, Goodfellow PN et al (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530 (Pubitemid 24368528)
7. Wagner T, Wirth J, Meyer J, Zabel B, Held M, Zimmer J, Pasantes J, Bricarelli FD, Keutel J, Hustert E et al (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120
8. Zhao Q, Eberspaecher H, Lefebvre V, De Crombrugghe B (1997) Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209:377-386 (Pubitemid 27328464)
9. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, Ling KW, Sham MH, Koopman P, Tam PP, Cheah KS (1997) SOX9 directly regulates the type-II collagen gene. Nat Genet 16:174-178 (Pubitemid 27240616)
10. Ng LJ, Wheatley S, Muscat GE, Conway-Campbell J, Bowles J, Wright E, Bell DM, Tam PP, Cheah KS, Koopman P (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183:108-121 (Pubitemid 27157837)
11. Leung KK, Ng LJ, Ho KK, Tam PP, Cheah KS (1998) Different cis-regulatory DNA elements mediate developmental stage- and tissue-specific expression of the human COL2A1 gene in transgenic mice. J Cell Biol 141:1291-1300 (Pubitemid 28289905)
12. Lefebvre V, Huang W, Harley VR, Goodfellow PN, De Crombrugghe B (1997) SOX9 is a potent activator of the chondrocytespecific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17:2336-2346 (Pubitemid 27133320)
13. Lefebvre V, Li P, de Crombrugghe B (1998) A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17:5718-5733 (Pubitemid 28445983)
14. Bernard P, Tang P, Liu S, Dewing P, Harley VR, Vilain E (2003) Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet 12:1755-1765 (Pubitemid 36896667)
15. Sock E, Pagon RA, Keymolen K, Lissens W, Wegner M, Scherer G (2003) Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum Mol Genet 12:1439-1447 (Pubitemid 36758456)
16. Bridgewater LC, Lefebvre V, de Crombrugghe B (1998) Chondrocyte- specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273: 14998-15006 (Pubitemid 28272793)
17. Bridgewater LC, Walker MD, Miller GC, Ellison TA, Holsinger LD, Potter JL, Jackson TL, Chen RK, Winkel VL, Zhang Z et al (2003) Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res 31:1541-1553 (Pubitemid 36304916)
18. Han Y, Lefebvre V (2008) L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 28:4999-5013
19. Jenkins E, Moss JB, Pace JM, Bridgewater LC (2005) The new collagen gene COL27A1 contains SOX9-responsive enhancer elements. Matrix Biol 24:177-184 (Pubitemid 40732591)
20. Nagy A, Kenesi E, Rentsendorj O, Molnar A, Szenasi T, Sinko I, Zvara A, Oommen ST, Barta E, Puskas LG et al (2011) Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9. Mol Cell Biol 31:686-699
21. Rentsendorj O, Nagy A, Sinko I, Daraba A, Barta E, Kiss I (2005) Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene. Biochem J 389:705-716 (Pubitemid 41117330)
22. Xie WF, Zhang X, Sakano S, Lefebvre V, Sandell LJ (1999) Trans-activation of the mouse cartilage-derived retinoic acidsensitive protein gene by Sox9. J Bone Miner Res 14:757-763 (Pubitemid 29210602)
23. Bi W, Huang W, Whitworth DJ, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98:6698-6703 (Pubitemid 32538279)
24. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B (1999) Sox9 is required for cartilage formation. Nat Genet 22:85-89 (Pubitemid 29214811)
25. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-2828 (Pubitemid 35253149)
26. Smits P, Li P, Mandel J, Zhang Z, Deng JM, Behringer RR, de Croumbrugghe B, Lefebvre V (2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-290 (Pubitemid 33653062)
27. Smits P, Dy P, Mitra S, Lefebvre V (2004) Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 164:747-758 (Pubitemid 38282958)
28. Akiyama H, Stadler HS, Martin JF, Ishii TM, Beachy PA, Nakamura T, de Crombrugghe B (2006) Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. Matrix Biol 26:224-233 (Pubitemid 46661984)
29. Haudenschild DR, Chen J, Pang N, Lotz MK, D'Lima DD (2011) Rho kinase-dependent activation of SOX9 in chondrocytes. Arthritis Rheum 62:191-200
30. Huang W, Zhou X, Lefebvre V, de Crombrugghe B (2000) Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 20:4149-4158 (Pubitemid 30314512)
31. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B (2001) The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98:160-165 (Pubitemid 32095880)
32. Hattori T, Coustry F, Stephens S, Eberspaecher H, Takigawa M, Yasuda H, de Crombrugghe B (2008) Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5. Nucleic Acids Res 36:3011-3024 (Pubitemid 351737193)
33. Hattori T, Eberspaecher H, Lu J, Zhang R, Nishida T, Kahyo T, Yasuda H, de Crombrugghe B (2006) Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem 281:14417-14428 (Pubitemid 43848372)
34. Oh HJ, Kido T, Lau YF (2007) PIAS1 interacts with and represses SOX9 transactivation activity. Mol Reprod Dev 74:1446-1455 (Pubitemid 47479962)
35. Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, Zhang Z, Martin JF, Behringer RR, Nakamura T et al (2005) Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 102:14665-14670 (Pubitemid 41457113)
36. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764 (Pubitemid 27516178)
37. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771 (Pubitemid 27516179)
38. Day TF, Guo X, Garrett-Beal L, Yang Y (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8:739-750 (Pubitemid 40585296)
39. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C (2005) Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8:727-738 (Pubitemid 40585295)
40. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR et al (2004) Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087 (Pubitemid 38620246)
41. Topol L, Chen W, Song H, Day TF, Yang Y (2009) Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 284:3323-3333
42. Zhou G, Zheng Q, Engin F, Munivez E, Chen Y, Sebald E, Krakow D, Lee B (2006) Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103:19004-19009 (Pubitemid 350002818)
43. Cheng A, Genever PG (2010) SOX9 determines RUNX2 transactivity by directing intracellular degradation. J Bone Miner Res 25:2404-2413
44. Amano K, Hata K, Muramatsu S, Wakabayashi M, Takigawa Y, Ono K, Nakanishi M, Takashima R, Kogo M, Matsuda A et al (2011) Arid5a cooperates with sox9 to stimulate chondrocytespecific transcription. Mol Biol Cell 22:1300-1311
45. Huang W, Lu N, Eberspaecher H, De Crombrugghe B (2002) A new long form of c-Maf cooperates with Sox9 to activate the type II collagen gene. J Biol Chem 277:50668-50675 (Pubitemid 36042228)
46. Kawakami Y, Tsuda M, Takahashi S, Taniguchi N, Esteban CR, Zemmyo M, Furumatsu T, Lotz M, Belmonte JC, Asahara H (2005) Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci USA 102:2414-2419 (Pubitemid 40279390)
47. Takigawa Y, Hata K, Muramatsu S, Amano K, Ono K, Wakabayashi M, Matsuda A, Takada K, Nishimura R, Yoneda T (2010) The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9. J Cell Sci 123:3780-3788
48. Hata K, Nishimura R, Muramatsu S, Matsuda A, Matsubara T, Amano K, Ikeda F, Harley VR, Yoneda T (2008) Paraspeckle protein p54 links Sox9-mediated transcription with RNA processing during chondrogenesis in mice. J Clin Invest 118:3098-3108
49. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M, Asahara H (2005) Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 280:35203-35208 (Pubitemid 41532707)
50. Tsuda M, Takahashi S, Takahashi Y, Asahara H (2003) Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278:27224-27229 (Pubitemid 36876879)
51. Zhou R, Bonneaud N, Yuan CX, de Santa Barbara P, Boizet B, Schomber T, Scherer G, Roeder RG, Poulat F, Berta P (2002) SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res 30:3245-3252 (Pubitemid 34846188)
52. Rau MJ, Fischer S, Neumann CJ (2006) Zebrafish Trap230/ Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development. Dev Biol 296:83-93 (Pubitemid 44061756)
53. Nakamura Y, Yamamoto K, He X, Otsuki B, Kim Y, Murao H, Soeda T, Tsumaki N, Deng JM, Zhang Z et al (2011) Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat Commun 2:251
54. Lee HK, Park UH, Kim EJ, Um SJ (2007) MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. EMBO J 26:3545-3557
55. Rana R, Surapureddi S, Kam W, Ferguson S, Goldstein JA (2011) Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver. Mol Cell Biol 31:466-481
56. Youn HS, Park UH, Kim EJ, Um SJ (2011) PTOV1 antagonizes MED25 in RAR transcriptional activation. Biochem Biophys Res Commun 404:239-244